Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms
Year: 2006
Type: article
Study design: Observational Study
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
Funder: Vetenskapsrådet
OpenAlex ID: W1985020104
